Mark Schultz & Jennifer Brant

Jun 2, 2026

Congress Should Demand Evidence on Drug Patents, Not Metaphors

This week, a House Judiciary subcommittee will revisit familiar accusations about pharmaceutical patents and drug prices. Testimony will likely invoke two concepts: that drug...